|
|
|
Volumn 52, Issue 10, 2003, Pages 754-756
|
|
Estrogen plus progestin may increase incidence of dementia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ESTROGEN;
GESTAGEN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MEDROXYPROGESTERONE ACETATE;
PLACEBO;
AGED;
AGING;
ALZHEIMER DISEASE;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMENTIA;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG SCREENING;
DRUG UTILIZATION;
ESTROGEN ACTIVITY;
ESTROGEN THERAPY;
FEMALE;
FOLLOW UP;
HIGH RISK POPULATION;
HUMAN;
INCIDENCE;
MAJOR CLINICAL STUDY;
MINI MENTAL STATE EXAMINATION;
NEUROPSYCHOLOGICAL TEST;
OUTCOMES RESEARCH;
PATIENT COMPLIANCE;
PHYSICAL EXAMINATION;
POSTMENOPAUSE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
SCORING SYSTEM;
STROKE;
AGED;
COGNITION DISORDERS;
DEMENTIA;
DOUBLE-BLIND METHOD;
DRUG COMBINATIONS;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS;
FEMALE;
HUMANS;
INCIDENCE;
MEDROXYPROGESTERONE 17-ACETATE;
POSTMENOPAUSE;
RANDOMIZED CONTROLLED TRIALS;
REPRODUCIBILITY OF RESULTS;
UNITED STATES;
|
|
EID: 0141954059
PISSN: 00943509
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (1)
|
